EHA Endorsement of the European Guidelines for Myelodysplastic Syndromes, MDS-RIGHT

EHA Endorsement of the European Guidelines for Myelodysplastic Syndromes, MDS-RIGHT

Bibliographic Details
Main Authors:	Sabine Blum, Luca Malcovati, on behalf of the EHA Guidelines Committee*
Format:	Article
Language:	English
Published:	Wolters Kluwer 2021-09-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000631

Similar Items

EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone Lymphomas
by: Marco Ladetto, et al.
Published: (2020-04-01)

EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma
by: Kim Linton, et al.
Published: (2020-10-01)

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up of Chronic Lymphocytic Leukemia
by: Barbara Eichhorst, et al.
Published: (2021-01-01)

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Waldenström’s Macroglobulinemia
by: Philipp B. Staber, et al.
Published: (2021-10-01)

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
by: Meletios A. Dimopoulos, et al.
Published: (2021-02-01)

EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma
by: Marco Ladetto, et al.
Published: (2021-05-01)

The role of azacitidine in the management of myelodysplastic syndromes (MDS)
by: KS G&ouml;tze, et al.
Published: (2009-10-01)

Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)
by: Gattermann, N., et al.
Published: (2022)

Cytogenetic study of Brazilian patients with myelodysplastic syndrome (MDS)
by: Tamara Borgonovo, et al.
Published: (2005-12-01)

Myelodysplastic syndromes (MDS): prognostic factors and scoring systems
by: Elizabeth Xisto Souto, et al.

Genes differentially expressed in adult familial myelodysplastic syndromes (MDS)
by: Pradhan, Anjala Vinayak
Published: (2003)

Myelodysplastic syndrome(MDS)の造血障害に関する研究
by: Ohmori, Seiichi
Published: (2013)

An Investigation into the Molecular Pathogenesis of the Myelodysplastic Syndromes (MDS), in Particular the 5q- Syndrome
by: Watkins, Fiona
Published: (2010)

Current State and Challenges in Development of Targeted Therapies in Myelodysplastic Syndromes (MDS)
by: Michele Stanchina, et al.
Published: (2021-04-01)

Cost-effectiveness of azacitidine compared with low-doses of chemotherapy (LDC) in myelodysplastic syndrome (MDS)
by: Myrna Candelaria-Hernández, et al.
Published: (2017-06-01)

Management of myelodysplastic syndromes: Expert consensus opinion from the Saudi MDS Working Group
by: Ahmed Alaskar, et al.
Published: (2014-01-01)

Hematologic improvements in a myelodysplastic syndromes with myelofibrosis (MDS-F) patient treated with azacitidine
by: Daisuke Okamura, et al.
Published: (2014-01-01)

Changing the Pathobiological Paradigm in Myelodysplastic Syndromes: The NLRP3 Inflammasome Drives the MDS Phenotype
by: Basiorka, Ashley
Published: (2017)

EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Mold Infection: An Initiative of the European Confederation of Medical Mycology in Cooperation With International Society for Human and Animal Mycology and American Society for Microbiology
by: Rosanne Sprute, et al.
Published: (2021-03-01)

EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Yeast Infections: An Initiative of the European Confederation of Medical Mycology in Cooperation With the International Society for Human and Animal Mycology and American Society for Microbiology
by: Jannik Stemler, et al.
Published: (2021-10-01)

Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
by: Jan Philipp Bewersdorf, et al.
Published: (2021-03-01)

The EHA Research Roadmap: Malignant Myeloid Diseases
by: Hartmut Döhner, et al.
Published: (2021-09-01)

Affordability of Medicines a Top Priority for EHA: Toward a Fair Pricing Model for Innovative Medicines
by: Anton Hagenbeek, et al.
Published: (2017-12-01)

Guidelines for Myelodysplastic Syndromes: Converting Evidence into Action?
by: Annika Kasprzak, et al.
Published: (2021-07-01)

Guidelines for the Diagnosis and Treatment of Myelodysplastic Syndromes in Adults
by: Uroš Mlakar
Published: (2010-06-01)

An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms
by: Mughal, T.I, et al.
Published: (2015)

Myelodysplastic Syndrome (MDS) in a Child who Transformed to Acute Myeloid Leukaemia with Myelodysplasia-Related Changes (AML-MRC)
by: Ni Komang Ayu Parmawati, et al.
Published: (2019-08-01)

The EHA Research Roadmap: Anemias
by: Achille Iolascon, et al.
Published: (2021-07-01)

The EBMT/EHA CAR-T Cell Handbook
Published: (2022)

The EHA Research Roadmap: Platelet Disorders
by: Carlo Balduini, et al.
Published: (2021-07-01)

The EBMT/EHA CAR-T Cell Handbook
Published: (2022)

Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS).
by: IOANNIS KOTSIANIDIS
Published: (2019-06-01)

Validation of International Working Group response criteria in higher‐risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium
by: Rami S. Komrokji, et al.
Published: (2021-01-01)

Caspase-3 activation by Iysosomal enzymes in cytochrome c-independent apoptosis in a myelodysplastic syndrome(MDS)-derived cell line P39.
by: Hishita, Terutoshi
Published: (2011)

The EHA Research Roadmap: Blood Coagulation and Hemostatic Disorders
by: Sabine Eichinger, et al.
Published: (2021-10-01)

Correction Notice: Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
Published: (2021-04-01)

EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update
by: Achille Iolascon, et al.
Published: (2019-06-01)

Telemedicine networks of EHAS Foundation in Latin America
by: Ignacio ePrieto-Egido, et al.
Published: (2014-10-01)

Correction Notice: The EHA Research Roadmap: Anemias
Published: (2021-10-01)

EHA2021 Virtual Congress Abstract Book
Published: (2021-06-01)